Regulatory Story
Go to market news section View chart   Print
RNS
GlaxoSmithKline PLC   -  GSK   

Director/PDMR Shareholding

Released 16:46 14-Jan-2020

RNS Number : 7967Z
GlaxoSmithKline PLC
14 January 2020
 

GlaxoSmithKline plc (the 'Company')

 

Transaction notification

 

 

 

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Mr B McNamara

b)

Position/status

CEO, GSK Consumer Healthcare

c)

Initial notification/

amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial instrument

American Depositary Shares ('ADSs')

ISIN: US37733W1053

 

b)

Nature of the transaction

Acquisition of ADSs following the re-investment of dividends paid to shareholders on 9 January 2020 on ADSs held in the Deferred Annual Bonus Plan Post-Tax.

c)

Price(s) and volume(s)


Price(s)

Volume(s)



$47.0819

24.753






d)

Aggregated information

 

N/A (single transaction)

Aggregated volume Price


e)

Date of the transaction

2020-01-10

f)

Place of the transaction

 

New York Stock Exchange (XNYS)

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHQZLFFBFLZBBL
Close


London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.

 


Director/PDMR Shareholding - RNS